AI News NQ Analysis

PharmaEssentia: March 2026 Monthly Revenue NT$1.94 Billion (YoY +64.4%)

NQ Score 4/100
N1 Content Completeness 4

AI Summary (NQ-processed)

PharmaEssentia announced its March 2026 monthly revenue reached NT$1.94 billion, marking a substantial year-on-year increase of 64.4%. This strong performance highlights the company's robust growth within the biotechnology and medical industry.

AI Analysis

Frequently Asked Questions

Q: What was PharmaEssentia's revenue in March 2026?
A: PharmaEssentia's monthly revenue for March 2026 was NT$1.94 billion (NT$1,940,196 thousand).
Q: How much did it increase compared to the same month last year?
A: It recorded a significant increase of 64.4% compared to the same month last year.
Q: What industry does PharmaEssentia belong to?
A: PharmaEssentia belongs to the biotechnology and medical industry.